Doximity shares soar 21% after company beats on revenue, raises fiscal-year guidance

Doximity shares soar 21% after company beats on revenue, raises fiscal-year guidance


Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.

Source: NYSE

Shares of Doximity popped 21% on Thursday after the company reported third-quarter fiscal 2025 results that beat analysts’ expectations for revenue and offered rosy guidance.

Here’s how the company did:

  • Earnings per share: 37 cents, may not compare with the 34 cents expected by LSEG
  • Revenue: $168.6 million vs. $152.8 million expected by LSEG

Doximity is a digital platform for medical professionals that helps clinicians stay current on medical news, manage paperwork, find referrals and carry out telehealth appointments with patients. The company primarily generates revenue through its telehealth tools, hiring solutions and marketing offerings for clients such as pharmaceutical companies.

Doximity’s revenue increased 25% in its third quarter from $135.3 million during the same period last year, according to a release.

For its fiscal fourth quarter, Doximity said it expects to report revenue between $132.5 million and $133.5 million, compared with analysts’ estimates of $123.8 million.

The company also raised guidance for its full fiscal year, and said it expects to report revenue between $564.6 million and $565.6 million, up from the range the company shared last quarter, when it expected $535 million to $540 million. Analysts were expecting $540 million for the year.

“We’re proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools,” Doximity CEO Jeff Tangney said in a statement. “Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers.”

The company reported net income of $75.2 million, or 37 cents per share, during its third quarter, up from $48.0 million, or 24 cents per share, a year prior. Doximity’s adjusted EBITDA was $102.0 million, up 39% year over year.

Doximity has been a bright spot within the battered digital health sector, which has faced a reckoning as companies have had to adjust to a more muted growth environment. The company’s stock price more than doubled in 2024.

Don’t miss these insights from CNBC PRO



Source

India says US trade negotiations are still going on as fresh tariffs loom
World

India says US trade negotiations are still going on as fresh tariffs loom

Dr. Subrahmanyam Jaishankar, Indian Minister of External Affairs at the World Trade Center on June 30, 2025 in New York City. Roy Rochlin | Getty Images Entertainment | Getty Images India’s foreign minister said on Saturday that trade negotiations with Washington are continuing but there are lines that New Delhi needs to defend, just days […]

Read More
China proposes draft rules on internet platform pricing
World

China proposes draft rules on internet platform pricing

Aerial view of vehicles being driven on the road through the central business district in Beijing, China. Vcg | Visual China Group | Getty Images China proposed rules for internet platform pricing on Saturday, seeking public comment after a raft of complaints by merchants and consumers of unfair or misleading pricing by big platforms. The […]

Read More
Inside billionaire Lucy Guo’s intense daily routine: 5:30 a.m. wake-ups, double gym sessions, and no lunch breaks
World

Inside billionaire Lucy Guo’s intense daily routine: 5:30 a.m. wake-ups, double gym sessions, and no lunch breaks

Lucy Guo, founder and CEO of Passes. Passes Lucy Guo might be a billionaire, but instead of a life of luxury and comfort, she swears by a relentless work ethic and strict daily routine. At just 30 years old, the California-born-and-raised entrepreneur has achieved what many will spend their lifetimes chasing. In April, Guo’s net […]

Read More